234 related articles for article (PubMed ID: 26238071)
1. Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs.
Lin SZ; Xu JB; Ji X; Chen H; Xu HT; Hu P; Chen L; Guo JQ; Chen MY; Lu D; Wang ZH; Tong HF
Mol Med Rep; 2015 Oct; 12(4):5865-71. PubMed ID: 26238071
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes.
Craven KE; Gore J; Wilson JL; Korc M
Oncotarget; 2016 Jan; 7(1):323-41. PubMed ID: 26586478
[TBL] [Abstract][Full Text] [Related]
3. Emodin inhibits pancreatic cancer EMT and invasion by up‑regulating microRNA‑1271.
Li N; Wang C; Zhang P; You S
Mol Med Rep; 2018 Sep; 18(3):3366-3374. PubMed ID: 30066876
[TBL] [Abstract][Full Text] [Related]
4. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
5. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
Thacker PC; Karunagaran D
PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis.
Lin SZ; Wei WT; Chen H; Chen KJ; Tong HF; Wang ZH; Ni ZL; Liu HB; Guo HC; Liu DL
PLoS One; 2012; 7(8):e42146. PubMed ID: 22876305
[TBL] [Abstract][Full Text] [Related]
7. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
[TBL] [Abstract][Full Text] [Related]
8. The Smad family and its role in pancreatic cancer.
Singh P; Wig JD; Srinivasan R
Indian J Cancer; 2011; 48(3):351-60. PubMed ID: 21921337
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
10. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor.
Wang H; Liu J; Zong Y; Xu Y; Deng W; Zhu H; Liu Y; Ma C; Huang L; Zhang L; Qin C
Brain Res; 2010 Oct; 1357():166-74. PubMed ID: 20709030
[TBL] [Abstract][Full Text] [Related]
11. Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.
Gore J; Imasuen-Williams IE; Conteh AM; Craven KE; Cheng M; Korc M
Cancer Lett; 2016 Aug; 379(1):143-53. PubMed ID: 27267807
[TBL] [Abstract][Full Text] [Related]
12. miR-202 Diminishes TGFβ Receptors and Attenuates TGFβ1-Induced EMT in Pancreatic Cancer.
Mody HR; Hung SW; Pathak RK; Griffin J; Cruz-Monserrate Z; Govindarajan R
Mol Cancer Res; 2017 Aug; 15(8):1029-1039. PubMed ID: 28373289
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
14. Sequential gonadotropin treatment of immature mice leads to amplification of transforming growth factor beta action, via upregulation of receptor-type 1, Smad 2 and 4, and downregulation of Smad 6.
Guéripel X; Benahmed M; Gougeon A
Biol Reprod; 2004 Mar; 70(3):640-8. PubMed ID: 14585817
[TBL] [Abstract][Full Text] [Related]
15. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
Wei WT; Chen H; Ni ZL; Liu HB; Tong HF; Fan L; Liu A; Qiu MX; Liu DL; Guo HC; Wang ZH; Lin SZ
Int J Oncol; 2011 Dec; 39(6):1381-90. PubMed ID: 21805032
[TBL] [Abstract][Full Text] [Related]
16. Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1.
Hoshino Y; Nishida J; Katsuno Y; Koinuma D; Aoki T; Kokudo N; Miyazono K; Ehata S
Am J Pathol; 2015 May; 185(5):1457-70. PubMed ID: 25769430
[TBL] [Abstract][Full Text] [Related]
17. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.
Yasutome M; Gunn J; Korc M
Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109
[TBL] [Abstract][Full Text] [Related]
18. Vasohibin-1 expression is regulated by transforming growth factor-β/bone morphogenic protein signaling pathway between tumor-associated macrophages and pancreatic cancer cells.
Shen Z; Seppänen H; Kauttu T; Vainionpää S; Ye Y; Wang S; Mustonen H; Puolakkainen P
J Interferon Cytokine Res; 2013 Aug; 33(8):428-33. PubMed ID: 23651239
[TBL] [Abstract][Full Text] [Related]
19. PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1.
Chen Y; Yu G; Yu D; Zhu M
J Exp Clin Cancer Res; 2010 Aug; 29(1):104. PubMed ID: 20684793
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D
PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
